Ferring Pharmaceuticals has joined Pharma.Aero’s collaborative platform for global life science manufacturers, expanding the network of organizations contributing to the advancement of pharmaceutical logistics. Its participation strengthens the exchange of expertise focused on improving innovation, efficiency, and coordination across the global pharma supply chain.

Learn more about the Life Science Manufacturers Advisory Platform

Ferring is a privately owned, research-driven specialty biopharmaceutical group dedicated to building families and helping people live better lives. The company is a global leader in reproductive medicine and is also active in gastroenterology and urology. Through sustained scientific development, Ferring supports patients from conception to birth and beyond.

With more than 7,000 employees operating in over 50 countries, and a strong commitment to research and development excellence, Ferring is positioned at the forefront of healthcare innovation. Its mission aligns with Pharma.Aero’s purpose of advancing structured collaboration and operational excellence across the life science logistics ecosystem.

Through its participation in Pharma.Aero’s Life Science Manufacturers Advisory Platform, Ferring Pharmaceuticals will contribute to ongoing industry dialogue and joint initiatives focused on strengthening the reliability and performance of global pharmaceutical supply chains.